301
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Translation, Cultural Adaptation and Validation of the Hill Bone Compliance to High Blood Pressure Therapy Scale to Nepalese Language

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 957-970 | Published online: 08 Apr 2022

References

  • World Health Organization. Noncommunicable diseases; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed August 21, 2021.
  • Centers for Disease Control and Prevention. Facts about hypertension; 2021. Available from: https://www.cdc.gov/bloodpressure/facts.htm. Accessed August 21, 2021.
  • Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260. doi:10.1016/S0140-6736(12)61766-8
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–619. doi:10.1016/S0140-6736(12)60861-7
  • Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–292. doi:10.1161/HYPERTENSIONAHA.119.14240
  • Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012;6:613–622. doi:10.2147/PPA.S34704
  • World Health Organization. Adherence to long-term therapies. Evidence for action; 2003. Available from: http://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1. Accessed August 23, 2021.
  • Chopra HK, Ram CVS. Recent guidelines for hypertension. Circ Res. 2019;124(7):984–986. doi:10.1161/CIRCRESAHA.119.314789
  • Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026
  • Tilea I, Petra D, Voidazan S, Ardeleanu E, Varga A. Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania. Patient Prefer Adherence. 2018;12:625–635. doi:10.2147/PPA.S162965
  • Alsolami F, Hou X-Y, Correa-Velez I. [PS 03-23] Factors affecting antihypertensive medications adherence among hypertensive patients in Saudi Arabia. J Hypertens. 2016;34(Supplement 1):e132. doi:10.1097/01.hjh.0000500233.12767.52
  • Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK, Morisky DE. Adherence to antihypertensive medications: population based follow up in Eastern Nepal. J Nepal Health Res Counc. 2015;13(29):38–42.
  • Abbas H, Kurdi M, Watfa M, Karam R. Adherence to treatment and evaluation of disease and therapy knowledge in Lebanese hypertensive patients. Patient Prefer Adherence. 2017;11:1949. doi:10.2147/PPA.S142453
  • Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One. 2013;8(4):e62775. doi:10.1371/journal.pone.0062775
  • Sheilini M, Hande HM, Prabhu M, et al. Antihypertensive prescription pattern, self-reported reasons for non adherence to antihypertensives and adherence to lifestyle practices among the elderly. J Clin Diagn Res. 2018;12(1):OC01–OC04.
  • Teshome DF, Bekele KB, Habitu YA, Gelagay AA. Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia. Integr Blood Press Control. 2017;10:1. doi:10.2147/IBPC.S128914
  • Roka T, Ghimire M. Medication adherence among hypertensive patients attending a Tertiary Care Hospital in Nepal. J Nepal Health Res Counc. 2019;17(4):521–527. doi:10.33314/jnhrc.v17i4.2337
  • Kim J, Bushnell CD, Lee HS, Han SW. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea. Hypertension. 2018;72(2):391–398. doi:10.1161/HYPERTENSIONAHA.118.11139
  • Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51(1):90–94. doi:10.1331/JAPhA.2011.09154
  • Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299–306. doi:10.1016/j.jclinepi.2009.06.011
  • Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–96. doi:10.1111/j.1751-7117.2000.tb00211.x
  • Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res. Methodol. 2011;11(1):149. doi:10.1186/1471-2288-11-149
  • Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica. 2012;46(2):279–289. doi:10.1590/S0034-89102012005000013
  • Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill–bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15(4):207–211. doi:10.3109/13814780903452150
  • Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the Polish adaptation of the Hill-bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16(1):87. doi:10.1186/s12872-016-0270-y
  • Nashilongo M, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5):565–578. doi:10.1007/s10557-017-6756-8
  • Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res. 2011;5(3):183–188. doi:10.1016/j.anr.2011.09.007
  • Nogueira-Silva L, Sá-Sousa A, Lima MJ, Monteiro A, Dennison-Himmelfarb C, Fonseca JA. Translation and cultural adaptation of the hill-bone compliance to high blood pressure therapy scale to Portuguese. Rev Port Cardiol. 2016;35(2):93–97. doi:10.1016/j.repc.2015.07.013
  • Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12(2):76–86.
  • Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357–362. doi:10.1097/01.hco.0000126978.03828.9e
  • Lambert EV, Steyn K, Stender S, Everage N, Fourie JM. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16(1):286.
  • Bhattarai H, McLachlan CS, Khanal P, et al. May measurement month 2019: an analysis of blood pressure screening results from Nepal. Eur Heart J Suppl. 2021;23(Supplement_B):B110–B113. doi:10.1093/eurheartj/suab042
  • Aryal KK, Mehata S, Neupane S, et al. The burden and determinants of non communicable diseases risk factors in Nepal: findings from a nationwide STEPS survey. PLoS One. 2015;10(8):e0134834. doi:10.1371/journal.pone.0134834
  • Shakya R, Shrestha S, Gautam R, et al. Perceived illness and treatment adherence to hypertension among patients attending a tertiary hospital in Kathmandu, Nepal. Patient Prefer Adherence. 2020;14:2287–2300. doi:10.2147/PPA.S270786
  • Shrestha R, Sapkota B, Khatiwada AP, et al. Translation, cultural adaptation and validation of General Medication Adherence Scale (GMAS) into the Nepalese Language. Patient Prefer Adherence. 2021;15:1873. doi:10.2147/PPA.S320866
  • World Population Review. Kathmandu Population 2021; 2021. Available from: https://worldpopulationreview.com/world-cities/kathmandu-population. Accessed March 21, 2022.
  • Number of health facilities in Province 3, Department of Health Services (2074/75), Nepal; 2020. Available from: https://publichealthupdate.com/number-of-health-facilities-in-province-3-nepal/. Accessed March 21, 2022.
  • Cheong AT, Tong SF, Sazlina SG. Validity and reliability of the Malay version of the Hill-bone compliance to high blood pressure therapy scale for use in primary healthcare settings in Malaysia: a cross-sectional study. Malays Fam Physician. 2015;10(2):36–44.
  • Costello AB, Osborne J. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval. 2005;10(1):7.
  • World Health Organization. Process of translation and adaptation of instruments. Geneva: World Health Organization; 2016: 2018.
  • Taber KS. The use of Cronbach’s alpha when developing and reporting research instruments in science education. Res Sci Educ. 2018;48(6):1273–1296. doi:10.1007/s11165-016-9602-2
  • Kaiser-Meyer-Olkin (KMO) test for sampling adequacy. Available from: https://www.statisticshowto.com/kaiser-meyer-olkin/. Accessed August 1, 2021.
  • Dhungana RR, Pandey AR, Shrestha N. Trends in the prevalence, awareness, treatment, and control of hypertension in Nepal between 2000 and 2025: a systematic review and meta-analysis. Int J Hypertens. 2021;2021:6610649. doi:10.1155/2021/6610649
  • Pan J, Hu B, Wu L, Wang H, Lei T, Liu Z. The translation, reliability and validity of the Chinese version of the Hill–bone compliance to high blood pressure therapy scale in adults with hypertension. Patient Prefer Adherence. 2020;14:1853. doi:10.2147/PPA.S268031